Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Rushnet Inc RSHN

Consumer Defensive Beverages - Soft Drinks
RushNet, Inc. operates under the name HeliosDX. HeliosDX is a national clinical reference laboratory offering high-complexity urine drug testing (UDT), behavioral drug testing, allergy droplet cards, oral fluids, and infectious disease (PCR). The Company provides management services and insurance billing services principally to clinical reference laboratories. It provides PGX testing through... see more

Bullboard (PINL:RSHN)

View:
Prev 1 2
Post by AveragePennyon Dec 28, 2021 12:27pm

Rushnet, Inc Through Its Subsidiaries heliosDX and Grandeza

Grandeza Healthcare will also post impressive revenue numbers in its first full year since its previous spin off from heliosDX. Grandeza Healthcare had a revised increased forecasted revenue target of ...more  
100
Post by AveragePennyon Sep 28, 2021 8:59am

RushNet Announce Major Roadmap Spanning 15 Months

Over the last 6 months, RushNet, Inc. has made a major transformational advance. Its controlling interest was purchased by Mr. Ashley Sweat. Since then, RushNet acquired heliosDX, a fast-growing ...more  
75
Post by AveragePennyon Sep 14, 2021 10:49am

RushNet, Inc Grandeza Healthcare Surpass 7.8 Million Revenue

HeliosDX combined with Grandeza Healthcare brings RushNet's annual revenue to a run rate exceeding $7,800,000 in comparison to August's previously announced trend towards $7.6 million combined ...more  
67
Post by AveragePennyon Aug 31, 2021 11:56am

RSHN Remain as a Rushnet Subsidiary Along With Grandeza

heliosDX, in the meantime, intends to close on the binding Letter of Intent it signed over the summer to acquire another sizable and profitable lab. Upon closing, heliosDX forecasts an annual combined ...more  
83
Post by AveragePennyon Aug 26, 2021 2:29pm

heliosDX Adds Artificial Intelligence

https://www.accesswire.com/661576/heliosdx-adds-artificial-intelligence-to-its-suite-of-diagnostics-services-and-solutions This is a major upgrade to heliosDX and our infectious disease platform ...more  
59
Post by AveragePennyon Aug 23, 2021 3:16pm

RSHN Closes its 2nd Recent Acquisition

https://www.otcmarkets.com/stock/RSHN/news?id=317614 Grandeza was formed in January 2021, as a spin-out of its operations from heliosDX. Grandeza is a billing and coding company in the Healthcare ...more  
56
Post by AveragePennyon Aug 17, 2021 12:43pm

$RSHN Pursuit of TSX-V Listing

https://www.accesswire.com/660135/heliosdx-announces-pursuit-of-tsx-v-listing-and-roadmap-update The benefits of the listing we will be pursuing, if successful, should allow heliosDX to ...more  
88
Prev 1 2
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities